Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
04/2003
04/23/2003EP1057032B1 Treating cancer
04/23/2003EP1057031B1 Treating cancer
04/23/2003EP1057030B1 Treating cancer
04/23/2003EP1057029B1 Treating cancer
04/23/2003EP1057028B1 Treating cancer
04/23/2003EP1019503A4 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides
04/23/2003EP0871654B1 Protegrins
04/23/2003EP0763982B1 Novel bioemulsifiers
04/23/2003EP0714439B1 Recombinant humanized anti-human immunodeficiency virus antibody
04/23/2003EP0672145B1 Interleukin-3 (il-3) multiple mutation polypeptides
04/23/2003EP0669978B1 Flk-1 is a receptor for vascular endothelial growth factor
04/23/2003EP0612348B1 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
04/23/2003EP0546124B2 Multidomain hematopoiesis stimulators
04/23/2003EP0483249B1 Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators
04/23/2003CN1413259A Method for producing protein hydrolysate
04/23/2003CN1413220A Anti-prostate stem cell antigen (PSCA) antibody compositions and method of use
04/23/2003CN1413219A Molecular structure of RHD negative genes locus
04/23/2003CN1412562A Preparation method of reagent for diagnosing cardiac infarction and its active components
04/23/2003CN1412313A Expression of recombinant human troponin I in colibacillus and its application for resisting tumor
04/23/2003CN1412312A Expression of recombinant human quick skeletal muscle type troponin C in colibacillus and its application for resisting tumor
04/23/2003CN1412310A Enzyme with protease activity
04/23/2003CN1106203C Chlamydia vaccine and process
04/22/2003US6552180 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-2 and uses thereof
04/22/2003US6552179 Mutant luciferases
04/22/2003US6552169 Density enhanced protein tyrosine phosphatases
04/22/2003US6551991 Recombinant proteins derived from HGF and MSP
04/22/2003US6551824 Designation MVP-5180/91, deposited with the European Collection of Animal Cell Cultures under No V 920 92 318
04/22/2003US6551823 EBV-infected stomach cancer cell line
04/22/2003US6551822 NL4 tie ligand homologue
04/22/2003US6551810 Polypeptide retains the ability to dephosphorylate an activated MAP-kinase
04/22/2003US6551800 Recombinant materials for production of a protein toxic to fire ants
04/22/2003US6551799 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of pancreatic defects
04/22/2003US6551797 Expression system for producing proteins
04/22/2003US6551794 Includes a protectant selected from a specified zwitterionic amino acid(s), trehalose, glycerol and ammonium sulphate, a buffer, and water soluble bulking agents; making fibrin; stabilized thrombin-like enzyme; sterility
04/22/2003US6551792 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
04/22/2003US6551775 Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1
04/22/2003CA2253636C Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
04/22/2003CA2207741C Variants of human papilloma virus antigens
04/22/2003CA2170757C Method of marking eukaryotic cells by the use of a cell surface receptor as a marker
04/22/2003CA2137793C Crystallization of m-csf
04/22/2003CA2098295C G protein-coupled glutamate receptors
04/22/2003CA2096975C Cell stress transcriptional factors
04/22/2003CA2076386C Identification and expression of insect steroid receptor dna sequence
04/22/2003CA1341427C Variants of immunoglobulin gene superfamily member
04/19/2003CA2408762A1 Antibodies for specifically detecting pathogenic prions of human origin, and detection methods carried out using these antibodies
04/17/2003WO2003031940A2 Structural and cytoskeleton-associated proteins
04/17/2003WO2003031939A2 Protein modification and maintenance molecules
04/17/2003WO2003031630A1 Multi-cistronic vectors for gene transfer protocols
04/17/2003WO2003031598A2 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
04/17/2003WO2003031596A2 Production of a highly active, soluble form of the cytochrome p450 reductase (cpr a) from candida tropicalis
04/17/2003WO2003031595A2 Molecules for disease detection and treatment
04/17/2003WO2003031590A2 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
04/17/2003WO2003031578A2 Mammalian c-type lectins
04/17/2003WO2003031577A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
04/17/2003WO2003031571A2 Novel human proteins, polynucleotides encoding them and methods of using the same
04/17/2003WO2003031568A2 Intracellular signaling molecules
04/17/2003WO2003031567A2 Precursor conversion screening methods
04/17/2003WO2003031566A2 Keratinocyte derived interferon
04/17/2003WO2003031476A1 Antibody of human origin for inhibiting thrombocytes aggregation
04/17/2003WO2003031475A2 Antibodies against kdr, their production and uses
04/17/2003WO2003031464A2 Remodeling and glycoconjugation of peptides
04/17/2003WO2003031462A2 Nogo receptor-mediated blockade of axonal growth
04/17/2003WO2003030833A2 Angiopoietin-2 specific binding agents
04/17/2003WO2003030831A2 Treatment of prostate cancer by inhibitors of atp synthase
04/17/2003WO2003030624A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof
04/17/2003WO2002094985A3 Beta-secretase substrates and uses thereof
04/17/2003WO2002085930A3 Immunomodulating agents from parasitic worms and method for isolation thereof
04/17/2003WO2002072863A3 Methods for large scale protein matching
04/17/2003WO2002070706A3 Interleukin-8 homologous polypeptides and therapeutic uses thereof
04/17/2003WO2002064615A3 Monoclonal antibodies to human immunodeficiency virus and uses thereof
04/17/2003WO2002050289A9 Methods for the production of multimeric proteins, and related compositions
04/17/2003WO2002033094A1 Antibody inhibiting vplf activity
04/17/2003WO2002029036A3 Lipid metabolism enzymes
04/17/2003WO2002027327A3 Rapid profiling of the interactions between a chemical entity and proteins in a given proteome
04/17/2003WO2002024891A3 B7-like molecules and uses thereof
04/17/2003WO2002020619A9 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3)
04/17/2003WO2002018575A3 Genes expressed in the cell cycle
04/17/2003WO2002012508A3 Method for improved production of cyanophycin and the secondary products thereof
04/17/2003WO2002000721A3 Cytokine receptor zcytor17
04/17/2003WO2001098366A3 Enterokinase cleavage sequences and their use
04/17/2003US20030073827 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
04/17/2003US20030073821 Antibody for use in human therapeutics and diagnostics
04/17/2003US20030073819 PGC-1, a novel brown fat PPARgamma coactivator
04/17/2003US20030073817 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders
04/17/2003US20030073813 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/17/2003US20030073810 Nucleotide sequence codin polypeptide for use in the diagnosis and treatment of nervous system and cancer disorders
04/17/2003US20030073809 Nucleotide sequence codin polypeptide for use in the diagnosis and treatment of nervous system and cancer disorders
04/17/2003US20030073655 Alzheimer's disease
04/17/2003US20030073627 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
04/17/2003US20030073624 Anticancer agents; isolated nucleic acids; genetic engineering
04/17/2003US20030073621 Antidiabetic agents; isolated nucleic acid; genetic engineering
04/17/2003US20030073620 Genetic engineering; antibody binding to nucleic acid; disease therapy
04/17/2003US20030073221 Hyaluronan synthase gene and uses thereof
04/17/2003US20030073216 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/17/2003US20030073215 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/17/2003US20030073214 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/17/2003US20030073213 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/17/2003US20030073212 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/17/2003US20030073211 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/17/2003US20030073210 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 ... 1125